Aceto supplies APIs to many generic drug companies. Aceto is a valued partner in their effort to develop and market generic drugs. The process of introducing a new API from pipeline to market spans a number of years and begins with Aceto partnering with a generic pharmaceutical manufacturer by selecting an API, several years before the expiration of a composition of matter patent, for future market sales. We then identify the appropriate supplier and concurrently utilize our global technical network to ensure they meet standards of quality to comply with regulations. Aceto has a pipeline of APIs at various stages of development both in the United States and Europe.
Additionally, Aceto can focus on developing API opportunities to provide alternative second-source options for existing generic drugs. By leveraging our worldwide sourcing, regulatory and quality assurance capabilities, we provide to generic drug manufacturers an alternative, rugged supply chain for existing API products.